Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vitro
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
other:
Endpoint conclusion
Endpoint conclusion:
no study available
Additional information:

The substance is classified as very toxic (T+) by ingestion, inhalation and absorption through the skin. As per Column 2 of Annex VII of REACH, no in vivo testing will be completed to quantify the skin sensitisation effect. The rationale for this decision is that the extreme toxicity of the substance would prove lethal to the test subjects before sensitisation could occur.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available
Additional information:

As per Column 2 of Annex VII of REACH, this endpoint is waived. This is because this substance is classified as very toxic (T+) by ingestion, inhalation and absorption through the skin or eyes, no testing has been done to quantify the respiratory sensitization effect. The rationale for this decision is that the extreme toxicity of the substance would prove lethal to the test subjects before sensitization could occur

Justification for classification or non-classification

No sensitisation data is available for TEL. However, the substance is classified in Annex I of the EU DSD as very toxic (T+) by ingestion, inhalation and absorption through the skin, and would be classified as acutely toxic by all routes of exposure according to EU regulations.